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Introduction: Persons with migraine often report being osmophobic, both during and 
between acute migraine attacks.  It is not clear, however, whether such reports are 
associated with true hypersensitivity to odors, as measured by psychophysical testing.   In 
this case-control study we quantitatively assessed olfactory identification ability, which 
correlates with threshold tests of olfactory sensitivity, in patients with migraine at 
baseline (no headache), during migraine episodes, and after a treated attack and compared 
the test scores to those of matched control subjects. 
Methods: Fifty episodic migraine subjects and 50 and sex- and age-matched controls 
without headache were tested. All completed University of Pennsylvania Smell 
Identification Test (UPSIT), a standardized and well-validated olfactory test.   
Results: At baseline, the UPSIT scores did not differ significantly between the migraine 
and control study groups (median paired score difference: -1, p = 0.18).  During migraine 
attacks, a minority of migraine subjects (8 of 42) developed microsmia (i.e., lower test 
scores by at least 4 points), suggesting that, as compared to their matched controls, 
olfactory acuity was somewhat impaired during migraine attacks (p = 0.02). This 
difference was less pronounced and not statistically significant after a successfully treated 
attack (p = 0.15). 
Discussion: 
Persons with episodic migraine were found to have similar olfactory function as age- and 
sex-matched controls, but a minority exhibit microsmia or hyposmia during acute attacks. 
The cause of this dysfunction is unknown, but could relate to autonomic symptoms, 
limbic system activation, or disorders of higher order sensory processing.   
Introduction 
Migraine is a complex neurologic disorder related to genetic and environmental factors 
consisting of headache, gastrointestinal symptoms, and multiple sensory disturbances 
including photophobia, phonophobia, and osmophobia in the absence of a causative 
secondary disorder. Hypersensitivity to sensory stimuli such as light and sound are 
classical diagnostic features of migraine [1], although migraineurs are also more likely to 
be bothered by odors than other persons. In fact, osmophobia may be a more specific 
symptom in differentiating migraine from other headache disorders [2,3], and including it 
as a diagnostic criterion may increase the sensitivity for accurately diagnosing migraine  
in populations where photophobia is less common [4]. Osmophobia is most prominent 
during acute migraine attacks, but discomfort may persist interictally in a subset of 
migraineurs [5].  
Olfactory impairment is a common symptom found in a number of neurologic disorders, 
such as Parkinson disease, schizophrenia and myasthenia gravis, possibly due to 
degeneration and/or dysmodulation of dopaminergic, serotonergic and cholinergic 
systems [6].  Multiple studies have confirmed that migraine subjects are bothered by 
odors, especially noxious stimuli [7,8], and that odors may precipitate attacks. One H2O-
PET study showed abnormal cerebral activation patterns during olfactory stimulation in 
migraineurs with olfactory hypersensitivity [9]. The ability of persons with migraine to 
detect and discriminate odors, as determined by standardized olfactory testing, is less 
clear. In one study, a large number of migraine subjects had poor olfactory acuity [10], as 
measured by olfactory thresholds, and in another migraineurs had increased odor 
detection [11]. A more recent study of episodic migraine subject found that their 
olfactory acuity was normal [5].  The effect of a migraine attack on olfactory ability 
during and after treated attacks is also unclear. 
The objective of this study was to examine olfactory acuity in episodic migraine subjects 
as compared with age and sex-matched controls, using a reliable and well-validated test 
of olfaction. We also evaluated the effect of migraine on olfaction – both during and after 
a treated attack.  
Methods 
Formal approval of this study was obtained from the Institutional Review Board at 
Thomas Jefferson University. Subjects ranging in age from 18 to 65 were recruited from 
our clinic and the surrounding community who were diagnosed with episodic migraine, 
as defined by the International Classification of Headache disorders 2nd edition. We 
excluded subjects or controls with a history of significant headache trauma, nasal or sinus 
disease, neurologic disorders such as Parkinson disease, dementia, or multiple sclerosis.  
Persons who used medications that could influence smell function, such as 
anticonvulsants or opioids, barbiturates or neuroleptics – drugs often used to treat attacks 
– were excluded from consideration.  Subjects were allowed to use simple or combination 
analgesics such as non-steroidal anti-inflammatory medications, including those with 
caffeine, and migraine-specific medications such as triptans. To ensure that we could 
determine the effect of a treated migraine on olfaction, we also excluded subjects which 
generally could not successfully treat migraines with medication. Due to the effect of 
gender and age on olfactory function [13], each subject was paired with a sex- and age-
matched (from -2 to 2 years) control without disabling headache or migraine. For the 
purposes of this study, controls were required to have a Migraine Disability Scale 
(MIDAS) score of zero. We did not specifically exclude persons with a family history of 
migraine. 
During the first visit we administrated a focused questionnaire to all participants to obtain 
basic demographic and medical history information.   We inquired as to whether odors 
caused them to develop headaches and whether any of five specific odors (perfume, 
paint, new carpet, gasoline, pesticides) were bothersome.  Both the subjects and the 
controls completed a validated questionnaire for allodynia [14]. The initial recruitment 
began June 2010 and final kits were received in October 2011. 
To determine olfactory function, all subjects completed the University of Pennsylvania 
Smell Identification Test (UPSIT), a well-validated and standardized 40-item forced 
choice olfactory test that is useful in detecting subtle olfactory deficits (12, 13). This test 
is more reliable, yet highly correlated, with traditional olfactory threshold tests. [15] 
There are a total of 40 odorants, with four booklets each containing ten odorants. The 
stimuli are embedded in “scratch and sniff” microcapsules at the bottom of each page. 
This inexpensive test is widely used clinically, and has been translated into 14 foreign 
languages.    
The UPSIT was administered at the time of their first visit, when the subjects received 
instructions on how to perform the test at home. After the initial visit, subjects took the 
UPSIT again at home or in the office during an acute migraine attack and completed a 
short clinical survey about their symptoms during the attacks, including severity, 
location, and aura, if present. They also completed the UPSIT a third time after a typical 
migraine with successful treatment (either mild or no pain), at least 2 hours after the 
attack. Based on previous studies using UPSIT to determine olfaction in various 
neurodegenerative disorders, and assuming a true difference between the mean UPSIT 
scores of 3 units, we determined that with 50 subjects there would be a 93% probability 
that the study will detect a statistically significant difference at a two-sided 5 percent 
significance level. We instructed 25 subjects to take the UPSIT at home during migraine, 
and to complete the final UPSIT after a treated attack. The other 25 subjects took the 
UPSIT after a treated attack first, then the final UPSIT during migraine. Controls 
repeated the UPSIT after the initial visit at least 2 weeks after the initial visit, and again at 
least another 2 weeks later. If subjects or controls completed the UPSIT at home, it was 
returned to our office in person or by mail.  
Data from the migraine patients and age/sex matched controls were analyzed to 
determine the association between migraine and olfactory acuity.  The baseline 
characteristics and scores between matched controls and migraine patients were paired 
and then compared. The paired data were skewed for UPSIT scores and other variables. 
To address this and test for significant differences between the migraine and control 
groups while accounting for the correlation within matched pairs, we applied the 
Wilcoxon Signed-Rank test of match-paired differences for continuous variables and 
McNemar’s test of discordant match-paired 2-level responses (or the more general Stuart-
Maxwell test of discordant match-paired multi-level responses) for categorical variables.  
For all tests, a significance level of α = 0.05 was used. We accounted for missing data 
(subjects or controls who didn’t return UPSIT kits) by comparing data with their matched 
pairs.  
Results 
Both the migraine and the control groups included 50 subjects who are matched by age 
and sex.  (Table 1.) There were no significant differences between the groups with 
respect to distributions of age, sex, height, weight or BMI, although more subjects were 
white race (76% vs. 66% white in migraineurs vs. controls, p = 0.36).  Allodynia was 
highly associated with migraine (92% subjects vs. 14% controls, p < 0.01). Of the 
migraine subjects, about 51% reported aura with visual aura being the most common and 
the majority (70%) experienced non-migraine headaches as well (Table 2). The majority 
of subjects (36/50 72%) reported a history of migraine of at least 10 years. 
Of those subjects who experience migraines, 32 (65%) indicated that they found odors to 
be bothersome, while only 7 (15%) of the controls did, demonstrating a significant 
association between group (migraine or control) and sensitivity to odors (Table 1). In 
terms of the matched pairs, 18 of 45 (40%) had responses which agreed while 27 (60%) 
had differing responses. Of those 27 responses, 25 (93%) were migraine subjects who 
found odors bothersome and controls who did not. This discordance strongly indicated a 
significant association between migraine and sensitivity to odors (p <0.01). 
The two groups had similar olfactory acuity at baseline, but the distribution of the match-
paired differences was skewed in the positive direction (Figure 1). At the time of the 
initial baseline visit, migraine subjects had a median UPSIT score of 36 (between 
attacks), while the controls had a median score of 37.  The median match-paired 
difference of -1 did not differ significantly from zero (p = 0.18).  Forty-two subjects 
completed the UPSIT during acute migraine and 40 completed the UPSIT after a treated 
migraine. Of the age-sex matched controls, 3 completed the UPSIT once after the initial 
visit and the other 47 completed both follow-up tests.  
Although the majority of migraine subjects had similar scores during migraine as in the 
initial visit (+/- 2 points), a minority had clinically significant decreases in acuity with 8 
(19%) scoring 4 or more points worse during acute migraine. Regardless, during their 
migraine attacks, the median UPSIT score for migraine subjects was still 36 as compared 
to 36 for controls at their second test; however, the median match-paired difference of -1 
was statistically significant (p = 0.02). This suggested that olfactory acuity during 
migraine was significantly impaired. After being treated, the median UPSIT of the 
migraineurs was again 36 compared to the median score of 37 among their matched 
controls at their third test. The median paired difference of -1 was not significantly 
different from zero (p = 0.15).  The histograms in Figure 2 present a visual distributional 
summary of changes in UPSIT test scores from baseline during attack (panel A.) and 
after successful treatment of attack (panel B.) for the migraine group.  
Considering a difference of three or more points on UPSIT to be clinically significant, 
thirteen migraine subjects had a decrease in UPSIT scores between baseline and during 
attacks of 3 points or greater, compared with 3 subjects after a treated attack. One patient 
had an increase in UPSIT of 4 points after a treated migraine, and no subject had an 
increase of greater than 3 points during migraine. Of the thirteen patients with clinically 
significantly lower scores during migraine, 12 reported allodynia during migraine, 8 had 
migraine with aura, 10 were female, and 9 reported a history of migraine greater than 10 
years.  
Discussion 
The results of this study suggest that the majority of patients with episodic migraine have 
normal olfactory function. This agrees with the studies of Saisu et al [5] and Hirsch [10] 
and supports the idea that migraine differs from neurodegenerative disorders such as 
Parkinson disease. However, a subgroup of our migraine subjects appeared to have 
experienced impairment during acute migraine, especially before successful treatment. 
This finding is similar to the 1992 study of Hirsch, which predates the classification of 
episodic and chronic migraine, in which 18% of migraine subjects were hyposmic or 
anosmic based on Pyridine odor threshold testing. The clinical and demographic 
characteristics of our migraine subjects who had significant olfactory impairment were 
not significantly different than those who did not in terms of allodynia, duration of 
disease, sex or age, although there was a trend for greater impairment in those with aura. 
The effect of migraine on olfaction was relatively modest in comparison to the olfactory 
dysfunction of neurodegenerative disorders [16] and other neurological disorders such as 
myasthenia gravis [17]. In a recent study of myasthenia gravis, 27 MG subjects exhibited 
a robust loss of olfaction relative to27 matched controls.  It is unclear if the decreased 
UPSIT scores in our subgroup of migraine subjects have clinical relevance. Our 
suggestion would be to test olfaction in patients with clinical symptoms of olfactory 
difficulties, especially those with a history of previous serious viral illness, head trauma 
or neurodegenerative disease. It should be noted that the subjects in this study were 
generally fairly healthy with treatable migraine attacks. In a separate study, we plan to 
examine subjects with chronic migraine including those without significant headache-free 
time.   
Our results confirmed several previous studies which confirm that persons with migraine 
report experiencing hypersensitivity to bothersome odors. The UPSIT is not a measure of 
osmophobia , is designed to be well-tolerated and did not trigger migraine attacks in this 
study. However, no subject in our study exhibited UPSIT scores that would suggest 
increased olfactory sensitivity during migraine (with an increase of more than 3 points on 
UPSIT). Although some persons with migraine may be more sensitive to odors even 
outside of attacks, our findings are in disaccord with those of Snyder and Drummond [11] 
who found migraineurs to have hyperosmia.   However, their test procedures differed 
from ours.  They studied 20 migraine subjects and 21 controls using odor detection 
thresholds for acetone and vanillin.   Acetone is a strong trigeminal stimulant and 
therefore is not a good measure of olfaction, per se. [18] Our findings are in agreement 
with the general notion that true hyperosmia is rare, regardless of the diseases involved. 
[19]. Taken together, olfactory hypersensitivity is more likely a perceptual distortion as 
opposed to one of increased threshold sensory function both interictally and during acute 
attacks. Persons with a sense of hyperacute odor detection usually do not have superior 
olfactory abilities. Pregnancy, for example, is not associated with hyperosmia. [20]  
Multiple factors influence olfaction including anatomic, genetic, and sensory processing 
differences. Changes in autonomic function are one possible cause of worsening olfaction 
during acute migraine. The sphenopalantine ganglion supplies autonomic projections to 
the nose. Increases in parasympathetic tone, which can manifest as tearing, swelling or 
congestion during migraine, is associated with engorgement of nasal turbinates [21]. 
Fluctuations in nasal engorgement are an overall indicator of autonomic tone [22] and 
correlate with measures such as rapid-eye movement sleep patterns [23] and cognitive 
abilities [24]. Allergic disorders are more common in persons with migraine and 
immunotherapy may be helpful to reduce migraine severity in younger patients [25]. It is 
possible that simple changes in autonomic tone during migraine could affect performance 
on the UPSIT.   
A more interesting potential explanation is that migraine affects areas in the brain which 
cause difficulty in perceiving odors when impaired. Pain-sensitive neurons from the 
thalamus project widely to multiple cortical regions, including the primary 
somatosensory cortex, the parietal association cortex, and the primary and secondary 
visual cortices. This suggests a mechanism for cortical dysfunction in migraine other than 
cortical spreading depression [26]. A recent functional MRI study found deficient 
habituation in the trigemino-nociceptive pathway, but not in the olfactory system 
suggesting the possibility that a thalamo-cortical network may be an important aspect of 
migraine as opposed to a single neuronal modulator. [27] Migraine is associated with 
activation of the amygdala and limbic system during acute attacks in a way similar to 
other pain disorders. The amygdala is highly involved in both odor intensity [28] and 
odor memory [29]. Since activation of the limbic system is a hallmark of pain disorders, 
it is possible that these changes may not be unique to migraine and olfactory abilities in 
other persons with episodic pain disorders remains unclear.   A minority of persons with 
migraine can experience olfactory hallucinations before or during headache, which 
usually involves a very specific and bothersome odor [30]. 
Olfactory problems in neurodegenerative diseases involve injury to dopaminergic, 
cholinergic, serotonergic, and noradrenergic systems, microglial activation and 
inflammation [6]. Although our subjects generally had normal olfaction at baseline, the 
development of hyposmia during attacks may indicate abnormal brain functioning, 
perhaps at the level of the basal ganglia or higher cortical structures [31]. Many common 
migraine premonitory symptoms, such as hunger or yawning, are also thought to be 
related to dopamine and linked to the hypothalamus [32].  
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 Table 1. Descriptive summary of study group characteristics. 
 Migraine 
n = 50  
Control 
n = 50 
 
p 
Age, n (%)   0.99 
<30 21 (42) 20 (40)  
30-39 12 (24) 12 (24)  
40-49 12 (24) 12 (24)  
50+ 5 (10) 6 (12)  
Sex, female, n (%) 37 (74) 36 (72) 0.99 
Race, n (%)   0.36 
White 38 (76) 33 (66)  
Black 11 (22) 6 (12)  
Asian 1 (2) 5 (10)  
Hispanic 0 (0) 4 (8)  
Others 0 (0) 2 (4)  
Height (in.), n (%)   0.93 
<66 24 (48) 24 (48)  
66-71 21 (42) 20 (40)  
72+ 5 (10) 6 (12)  
Weight (lbs.), n (%)   0.98 
100-149 18 (36) 19 (38)  
150-199 23 (46) 22 (44)  
200+ 9 (18) 9 (18)  
BMI, n (%)   0.09 
Normal (<25) 18 (36) 28 (56)  
Overweight (25-30) 21 (42) 12 (24)  
Obese (30+) 11 (22) 10 (20)  
Allodynia, n (%) 46 (92) 6 (14) <0.01 
>1 odors bothersome, n (%) 32 (65) 7 (15) <0.01 
BMI: body mass index (kg/m2) 
Table 2. Descriptive summary of migraine patient characteristics (n = 50). 
Age at onset, mean ± SD 18.8 ± 10.42 
Age at onset, n (%)  
<10 6 (13) 
10-19 23 (48) 
20-29 9 (19) 
30+ 10 (21) 
Aura, n (%) 25 (51) 
Aura Type*, n (%)  
None 26 (52) 
Blind spots 1 (2) 
Confused 1 (2) 
Sensory 6 (12) 
Visual 21 (42) 
Motor 2 (4) 
Non-Migraine HA, n (%) 35 (70) 
SD: standard deviation; HA: headache; * Multiple choices are possible so percentages 
may not add up to 100. 
 Table 3. Summary of UPSIT scores. 
 Migraine Control 
Paired  
Difference  
 
p* 
Interictal/Baseline, Median  36 37 -1 0.18 
Min-Max 30 - 40 30 - 40 -6 - 8  
mean ± SD 36.1 ± 2.5 36.6 ± 2.6 -0.48 ± 3.04  
During Attack/2nd Test, Median 36 36 -1 0.02 
Min-Max 27 - 40 25 - 40 -13 - 10  
mean ± SD 35.0 ± 3.2 35.9 ± 3.0 -1.29 ± 4.13  
After Attack/3rd Test, Median 36 37 -1 0.15 
Min-Max 22-40 29-40 -5 - 10  
mean ± SD 35.6 ± 3.2 36.2 ± 2.8 -0.55 ± 3.27  
* Wilcoxon Signed-Rank test of zero median difference (migraine minus control) in 
match-paired scores.  
 Figure 1. Difference in baseline olfactory acuity (UPSIT scores) between migraine 
patient and matched control pairs. 
 
 
 
 
Figure 2. Histograms of changes in migraine group UPSIT test scores from baseline 
during migraine attack (panel A.) and after attack (panel B.). 
A. 
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